NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球疤痕治療市場:按治療類型,疤痕類型,最終用戶行業分析和到2030年的增長預測

Scar Treatment Market Research Report: By Treatment Type, Scar Type, End User - Global Industry Analysis and Growth Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 971169
出版日期 內容資訊 英文 205 Pages
商品交期: 2-3個工作天內
價格
全球疤痕治療市場:按治療類型,疤痕類型,最終用戶行業分析和到2030年的增長預測 Scar Treatment Market Research Report: By Treatment Type, Scar Type, End User - Global Industry Analysis and Growth Forecast to 2030
出版日期: 2020年09月01日內容資訊: 英文 205 Pages
簡介

在過去幾年中,全球疤痕治療市場發展迅速,其增長因素包括皮膚疾病的發病率增加,公眾對外觀和外觀的認識增加,對疤痕治療的認識和疤痕形成的增加。其中包括快速的技術進步和治療創新以及可支配收入的增加。市場也有望繼續快速增長。

本報告研究了全球疤痕治療市場,包括市場規模,趨勢和機會,成長和抑制因素,治療類型/疤痕類型/最終用戶/區域市場分析,競爭狀況以及主要公司。提供諸如配置文件之類的信息。

目錄

第1章調查背景

  • 調查目的
  • 市場定義
  • 調查範圍
    • 按治療類型
    • 按疤痕類型
    • 最終用戶
    • 按地區
  • 分析期間
  • 市場數據報告單位
  • 主要利益相關者

第2章調查方法

第3章執行摘要

第4章簡介

  • 市場細分的定義
    • 按治療類型
      • 局部
      • 表面
      • 雷射
      • 注射
      • 手術
    • 按疤痕類型
      • 萎縮和痤瘡疤痕
      • 瘢痕roid和肥厚性瘢痕
      • 疤痕收縮
      • 妊娠紋
    • 最終用戶
      • 家庭
      • 醫院
      • 皮膚科診所
      • 其他
  • 市場動態
    • 趨勢
      • 對矽基疤痕治療產品的需求不斷增長
      • 疤痕治療產品在線零售的興起
    • 成長要因
      • 皮膚病患病率上升
      • 增加了消費者的外觀意識
      • 疤痕治療技術的進步
      • 個人對疤痕治療的意識增強
      • 可支配收入快速增長
      • 分析增長因素對市場預測的影響
    • 抑制要因
      • 疤痕治療產品和治療方法的副作用
      • 與疤痕治療產品相關的高成本
      • 分析限制因素對市場預測的影響
    • 市場機會
      • 對有機疤痕治療產品的需求增加
  • 波特五力分析
  • COVID-19的影響

第5章全球市場規模和預測

  • 按治療類型
    • 局部
    • 表面
    • 雷射
    • 注射
  • 按疤痕類型
  • 最終用戶
  • 按地區

第6章北美市場規模和預測

第7章歐洲市場規模和預測

第8章亞太市場規模和預測

第9章拉丁美洲市場規模和預測

第10章中東/非洲的市場規模和預測

第11章競爭情況

  • 主要公司的產品基準
  • 戰略發展
    • 產品發佈和批准
    • 收購
    • 其他發展

第12章公司簡介

  • Hologic Inc.
  • Candela Corporation
  • Avita Medical Limited
  • Molnlycke Health Care AB
  • Shanghai Fosun Pharmaceutical (Group) Company Limited
  • Smith & Nephew plc
  • Revitol Corporation
  • Sonoma Pharmaceuticals Inc.
  • CCA Industries Inc.
  • Scarguard Labs LLC
  • Quantum Inc.
  • Bausch Health Companies Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Johnson & Johnson

第13章附錄

  • 縮寫
  • 信息和參考
  • 相關報告
目錄
Product Code: LS10180

Title:
Scar Treatment Market Research Report: By Treatment Type (Topical, Surface, Laser, Injectable, Surgical), Scar Type (Atrophic and Acne Scar, Keloid and Hypertrophic Scar, Contracture Scar, Stretch Mark), End User (Home-Use, Hospitals, Dermatology Clinics) - Global Industry Analysis and Growth Forecast to 2030.

Due to the rising incidence of skin diseases, increasing consciousness amongst people about looks and appearance, surging awareness of scar treatment amongst the masses, rapid technological advancements and innovations in scar treatment, and the rising disposable income of people in several countries, the global scar treatment market grew rapidly during the last few years and is predicted to exhibit rapid progress in the future years as well, as per the findings of the market research company, P&S Intelligence.

As per a 2015 study carried out by the American Burn Association (ABA), 2,745 and 310 people died in residential fires and vehicle crash fires, respectively in that year. Further, 220 people died in various other fire accidents across the U.S. in 2015, as per the findings of the study. The rising incidence of such fire-related accidents has caused a sharp surge in the scar treatment market all over the globe.

The other important factor fueling the progress of the market is the increasing disposable income of people in many countries around the world. Moreover, people are becoming more conscious regarding their looks and appearance and are thus, spending more money on numerous skincare and grooming products. As per the findings of the U.S. Bureau of Labor Statistics, the personal disposable income of the people residing in the U.S. rose from $9,002.0 billion to $12,985.8 billion from 2004 to 2014 and is further predicted to grow to $19,874.5 billion in 2024.

On the basis of treatment type, the scar treatment market is classified into topical, laser, surface, surgical, and injectable categories. Amongst these, the topical division is predicted to register the fastest and highest growth in the market in the coming years. This is credited to the easier availability and lower prices of the topical scar treatment products such as oils, gels, and creams as compared to the other scar treatment products available in the market.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Treatment Type
    • 1.3.2 Market Segmentation by Scar Type
    • 1.3.3 Market Segmentation by End User
    • 1.3.4 Market Segmentation by Region
  • 1.4 Analysis Period
  • 1.5 Market Data Reporting Unit
  • 1.6 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Treatment Type
      • 4.1.1.1 Topical
        • 4.1.1.1.1 Cream
        • 4.1.1.1.2 Oil
        • 4.1.1.1.3 Gel
        • 4.1.1.1.4 Gel sheet
        • 4.1.1.1.5 Others
      • 4.1.1.2 Surface
        • 4.1.1.2.1 Dermabrasion
        • 4.1.1.2.2 Chemical peeling
        • 4.1.1.2.3 Cryosurgery
      • 4.1.1.3 Laser
        • 4.1.1.3.1 CO2 laser
        • 4.1.1.3.2 Er: YAG laser
        • 4.1.1.3.3 Pulsed-dye laser
        • 4.1.1.3.4 Others
      • 4.1.1.4 Injectable
        • 4.1.1.4.1 Tissue/dermal filler injection
        • 4.1.1.4.2 Steroid injection
      • 4.1.1.5 Surgical
    • 4.1.2 By Scar Type
      • 4.1.2.1 Atrophic and acne scar
      • 4.1.2.2 Keloid and hypertrophic scar
      • 4.1.2.3 Contracture scar
      • 4.1.2.4 Stretch mark
    • 4.1.3 By End User
      • 4.1.3.1 Home-use
      • 4.1.3.2 Hospitals
      • 4.1.3.3 Dermatology clinics
      • 4.1.3.4 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing demand for silicone-based scar treatment products
      • 4.2.1.2 Rising online retailing of scar treatment products
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing prevalence of skin diseases
      • 4.2.2.2 Rising appearance consciousness among consumers
      • 4.2.2.3 Technological advancements in scar treatment
      • 4.2.2.4 Growing awareness among individuals for scar treatment
      • 4.2.2.5 Surging disposable income
      • 4.2.2.6 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Side effects of scar treatment products and therapies
      • 4.2.3.2 High cost associated with scar treatment products
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Increasing demand for organic scar treatment products
  • 4.3 Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Buyers
    • 4.3.2 Bargaining Power of Suppliers
    • 4.3.3 Intensity of Rivalry
    • 4.3.4 Threat of New Entrants
    • 4.3.5 Threat of Substitutes
  • 4.4 Impact of COVID-19

Chapter 5. Global Market Size and Forecast

  • 5.1 Scar Treatment Market, by Treatment Type
    • 5.1.1 Topical Scar Treatment Market, by Type
    • 5.1.2 Surface Scar Treatment Market, by Type
    • 5.1.3 Laser Scar Treatment Market, by Type
    • 5.1.4 Injectable Scar Treatment Market, by Type
  • 5.2 Scar Treatment Market, by Scar Type
  • 5.3 Scar Treatment Market, by End User
  • 5.4 Scar Treatment Market, by Region

Chapter 6. North America Market Size and Forecast

  • 6.1 Scar Treatment Market, by Treatment Type
    • 6.1.1 Topical Scar Treatment Market, by Type
    • 6.1.2 Surface Scar Treatment Market, by Type
    • 6.1.3 Laser Scar Treatment Market, by Type
    • 6.1.4 Injectable Scar Treatment Market, by Type
  • 6.2 Scar Treatment Market, by Scar Type
  • 6.3 Scar Treatment Market, by End User
  • 6.4 Scar Treatment Market, by Country
    • 6.4.1 U.S. Scar Treatment Market
      • 6.4.1.1 Scar treatment market, by treatment type
      • 6.4.1.2 Scar treatment market, by scar type
    • 6.4.2 Canada Scar Treatment Market
      • 6.4.2.1 Scar treatment market, by treatment type
      • 6.4.2.2 Scar treatment market, by scar type

Chapter 7. Europe Market Size and Forecast

  • 7.1 Scar Treatment Market, by Treatment Type
    • 7.1.1 Topical Scar Treatment Market, by Type
    • 7.1.2 Surface Scar Treatment Market, by Type
    • 7.1.3 Laser Scar Treatment Market, by Type
    • 7.1.4 Injectable Scar Treatment Market, by Type
  • 7.2 Scar Treatment Market, by Scar Type
  • 7.3 Scar Treatment Market, by End User
  • 7.4 Scar Treatment Market, by Country
    • 7.4.1 Germany Scar Treatment Market
      • 7.4.1.1 Scar treatment market, by treatment type
      • 7.4.1.2 Scar treatment market, by scar type
    • 7.4.2 France Scar Treatment Market
      • 7.4.2.1 Scar treatment market, by treatment type
      • 7.4.2.2 Scar treatment market, by scar type
    • 7.4.3 U.K. Scar Treatment Market
      • 7.4.3.1 Scar treatment market, by treatment type
      • 7.4.3.2 Scar treatment market, by scar type
    • 7.4.4 Italy Scar Treatment Market
      • 7.4.4.1 Scar treatment market, by treatment type
      • 7.4.4.2 Scar treatment market, by scar type
    • 7.4.5 Spain Scar Treatment Market
      • 7.4.5.1 Scar treatment market, by treatment type
      • 7.4.5.2 Scar treatment market, by scar type

Chapter 8. APAC Market Size and Forecast

  • 8.1 Scar Treatment Market, by Treatment Type
    • 8.1.1 Topical Scar Treatment Market, by Type
    • 8.1.2 Surface Scar Treatment Market, by Type
    • 8.1.3 Laser Scar Treatment Market, by Type
    • 8.1.4 Injectable Scar Treatment Market, by Type
  • 8.2 Scar Treatment Market, by Scar Type
  • 8.3 Scar Treatment Market, by End User
  • 8.4 Scar Treatment Market, by Country
    • 8.4.1 China Scar Treatment Market
      • 8.4.1.1 Scar treatment market, by treatment type
      • 8.4.1.2 Scar treatment market, by scar type
    • 8.4.2 Japan Scar Treatment Market
      • 8.4.2.1 Scar treatment market, by treatment type
      • 8.4.2.2 Scar treatment market, by scar type
    • 8.4.3 India Scar Treatment Market
      • 8.4.3.1 Scar treatment market, by treatment type
      • 8.4.3.2 Scar treatment market, by scar type

Chapter 9. LATAM Market Size and Forecast

  • 9.1 Scar Treatment Market, by Treatment Type
    • 9.1.1 Topical Scar Treatment Market, by Type
    • 9.1.2 Surface Scar Treatment Market, by Type
    • 9.1.3 Laser Scar Treatment Market, by Type
    • 9.1.4 Injectable Scar Treatment Market, by Type
  • 9.2 Scar Treatment Market, by Scar Type
  • 9.3 Scar Treatment Market, by End User
  • 9.4 Scar Treatment Market, by Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 Scar Treatment Market, by Treatment Type
    • 10.1.1 Topical Scar Treatment Market, by Type
    • 10.1.2 Surface Scar Treatment Market, by Type
    • 10.1.3 Laser Scar Treatment Market, by Type
    • 10.1.4 Injectable Scar Treatment Market, by Type
  • 10.2 Scar Treatment Market, by Scar Type
  • 10.3 Scar Treatment Market, by End User
  • 10.4 Scar Treatment Market, by Country

Chapter 11. Competitive Landscape

  • 11.1 Product Benchmarking of Key Players
  • 11.2 Strategic Developments
    • 11.2.1 Product Launches and Approvals
    • 11.2.2 Acquisitions
    • 11.2.3 Other Developments

Chapter 12. Company Profiles

  • 12.1 Hologic Inc.
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Candela Corporation
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 Avita Medical Limited
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Molnlycke Health Care AB
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Shanghai Fosun Pharmaceutical (Group) Company Limited
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
  • 12.6 Smith & Nephew plc
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Revitol Corporation
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
  • 12.8 Sonoma Pharmaceuticals Inc.
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 CCA Industries Inc.
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Scarguard Labs LLC
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 Quantum Inc.
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Bausch Health Companies Inc.
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 Merz Pharma GmbH & Co. KGaA
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
  • 12.14 Johnson & Johnson
    • 12.14.1 Business Overview
    • 12.14.2 Product and Service Offerings
    • 12.14.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 HOUSEHOLD DISPOSABLE INCOME NET ANNUAL GROWTH RATE (%) (2018)
  • TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 AVERAGE COST OF DIFFERENT SCAR TREATMENTS
  • TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 6 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 7 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 8 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 9 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 10 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 11 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 12 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 13 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 14 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 15 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 16 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 17 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 18 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 19 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 20 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2014-2019)
  • TABLE 21 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2020-2030)
  • TABLE 22 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 23 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 24 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 25 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 26 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 27 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 28 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 29 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 30 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 31 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 32 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 33 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 34 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 35 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 36 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 37 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 38 U.S. SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 39 U.S. SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 40 U.S. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 41 U.S. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 42 CANADA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 43 CANADA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 44 CANADA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 45 CANADA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 46 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 47 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 48 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 49 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 50 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 51 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 52 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 55 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 56 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 57 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 58 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 59 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 60 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 61 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 62 GERMANY SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 63 GERMANY SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 64 GERMANY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 65 GERMANY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 66 FRANCE SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 67 FRANCE SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 68 FRANCE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 69 FRANCE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 70 U.K. SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 71 U.K. SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 72 U.K. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 73 U.K. SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 74 ITALY SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 75 ITALY SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 76 ITALY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 77 ITALY SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 78 SPAIN SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 79 SPAIN SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 80 SPAIN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 81 SPAIN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 82 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 83 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 84 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 89 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 90 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 91 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 92 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 93 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 94 APAC SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 95 APAC SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 96 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 97 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 98 CHINA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 99 CHINA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 100 CHINA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 101 CHINA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 102 JAPAN SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 103 JAPAN SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 104 JAPAN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 105 JAPAN SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 106 INDIA SCAR TREATMENT, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 107 INDIA SCAR TREATMENT, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 108 INDIA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 109 INDIA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 110 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 111 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 112 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 113 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 114 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 115 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 116 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 117 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 118 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 119 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 120 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 121 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 122 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 123 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 124 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 125 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 126 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2019)
  • TABLE 127 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2020-2030)
  • TABLE 128 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 129 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 130 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 131 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 132 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 133 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 134 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2019)
  • TABLE 135 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2020-2030)
  • TABLE 136 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2019)
  • TABLE 137 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2020-2030)
  • TABLE 138 MEA SCAR TREATMENT MARKET, BY END USER, $M (2014-2019)
  • TABLE 139 MEA SCAR TREATMENT MARKET, BY END USER, $M (2020-2030)
  • TABLE 140 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 141 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 142 HOLOGIC INC. - AT A GLANCE
  • TABLE 143 HOLOGIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 144 CANDELA CORPORATION - AT A GLANCE
  • TABLE 145 AVITA MEDICAL LIMITED - AT A GLANCE
  • TABLE 146 AVITA MEDICAL LIMITED - KEY FINANCIAL SUMMARY
  • TABLE 147 MOLNLYCKE HEALTH CARE AB - AT A GLANCE
  • TABLE 148 MOLNLYCKE HEALTH CARE AB - KEY FINANCIAL SUMMARY
  • TABLE 149 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) COMPANY LIMITED - AT A GLANCE
  • TABLE 150 SMITH & NEPHEW PLC - AT A GLANCE
  • TABLE 151 SMITH & NEPHEW PLC - KEY FINANCIAL SUMMARY
  • TABLE 152 REVITOL CORPORATION - AT A GLANCE
  • TABLE 153 SONOMA PHARMACEUTICALS INC. - AT A GLANCE
  • TABLE 154 SONOMA PHARMACEUTICALS INC. - KEY FINANCIAL SUMMARY
  • TABLE 155 CCA INDUSTRIES INC. - AT A GLANCE
  • TABLE 156 CCA INDUSTRIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 157 SCARGUARD LABS LLC - AT A GLANCE
  • TABLE 158 QUANTUM INC. - AT A GLANCE
  • TABLE 159 BAUSCH HEALTH COMPANIES INC. - AT A GLANCE
  • TABLE 160 BAUSCH HEALTH COMPANIES INC. - KEY FINANCIAL SUMMARY
  • TABLE 161 MERZ PHARMA GMBH & CO. KGAA - AT A GLANCE
  • TABLE 162 JOHNSON & JOHNSON - AT A GLANCE
  • TABLE 163 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL SCAR TREATMENT MARKET SUMMARY
  • FIG 9 PORTER'S FIVE FORCES ANALYSIS
  • FIG 10 GLOBAL SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 11 GLOBAL TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 12 GLOBAL SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 13 GLOBAL LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 14 GLOBAL INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 15 GLOBAL SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 16 GLOBAL SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 17 WORLDWIDE MAJOR MARKETS FOR SCAR TREATMENTS
  • FIG 18 GLOBAL SCAR TREATMENT MARKET, BY REGION, $M (2014-2030)
  • FIG 19 NORTH AMERICA SCAR TREATMENT MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 21 NORTH AMERICA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 22 NORTH AMERICA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 23 NORTH AMERICA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 24 NORTH AMERICA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 25 NORTH AMERICA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 26 NORTH AMERICA SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 27 NORTH AMERICA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 28 EUROPE SCAR TREATMENT MARKET SNAPSHOT
  • FIG 29 EUROPE SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 30 EUROPE TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 31 EUROPE SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 32 EUROPE LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 33 EUROPE INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 34 EUROPE SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 35 EUROPE SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 36 EUROPE SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 37 APAC SCAR TREATMENT MARKET SNAPSHOT
  • FIG 38 APAC SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 39 APAC TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 40 APAC SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 41 APAC LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 42 APAC INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 APAC SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 44 APAC SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 45 APAC SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 46 LATAM SCAR TREATMENT MARKET SNAPSHOT
  • FIG 47 LATAM SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 48 LATAM TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 49 LATAM SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 LATAM LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 LATAM INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 52 LATAM SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 53 LATAM SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 54 LATAM SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 55 MEA SCAR TREATMENT MARKET SNAPSHOT
  • FIG 56 MEA SCAR TREATMENT MARKET, BY TREATMENT TYPE, $M (2014-2030)
  • FIG 57 MEA TOPICAL SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 58 MEA SURFACE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 59 MEA LASER SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 60 MEA INJECTABLE SCAR TREATMENT MARKET, BY TYPE, $M (2014-2030)
  • FIG 61 MEA SCAR TREATMENT MARKET, BY SCAR TYPE, $M (2014-2030)
  • FIG 62 MEA SCAR TREATMENT MARKET, BY END USER, $M (2014-2030)
  • FIG 63 MEA SCAR TREATMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 64 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 65 HOLOGIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 66 AVITA MEDICAL LIMITED - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 67 MOLNLYCKE HEALTH CARE AB - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 68 SMITH & NEPHEW PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 69 SONOMA PHARMACEUTICALS INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2020)
  • FIG 70 CCA INDUSTRIES INC. - REVENUE SPLIT BY PRODUCT CATEGORY (2018)
  • FIG 71 BAUSCH HEALTH COMPANIES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 72 JOHNSON & JOHNSON - REVENUE SPLIT BY BUSINESS SEGMENT AND GEOGRAPHY (2019)